| 1 |
30332940 | Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents. | 2020 |
1 |
| 2 |
30052654 | Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid. | 2018 |
2 |
| 3 |
27239721 | Inhibitors of histone deacetylase as antitumor agents: A critical review. | 2016 Aug |
1 |
| 4 |
26111036 | The role of butyrate, a histone deacetylase inhibitor in diabetes mellitus: experimental evidence for therapeutic intervention. | 2015 |
1 |
| 5 |
24511897 | Suppression of adipogenesis by valproic acid through repression of USF1-activated fatty acid synthesis in adipocytes. | 2014 May 1 |
2 |
| 6 |
25320679 | Butyrate and other short-chain fatty acids increase the rate of lipolysis in 3T3-L1 adipocytes. | 2014 |
1 |
| 7 |
22323521 | Lactate, a product of glycolytic metabolism, inhibits histone deacetylase activity and promotes changes in gene expression. | 2012 Jun |
2 |
| 8 |
12769690 | Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics? | 2003 Jun |
2 |
| 9 |
12840228 | Inhibition of histone deacetylase activity by butyrate. | 2003 Jul |
2 |
| 10 |
12678732 | Histone deacetylase inhibitors and anticancer therapy. | 2002 Jul |
1 |